DYRK2 has also, in another study, been demonstrated to repress mTORC1 activation as mTORC1 activation was increased, with increased phosphorylation of S6K and 4E-BP1, in DYRK2 KD breast cancer cells. Here, DYRK2 is linked to breast carcinoma.